今日VC

venture capital & Private Equity

Entries for 七月, 2009

Dormir, Inc. Completes $12M Series A Financing

Proceeds to be used to Address Sleep Disorders through Expanded Commercial Operations of its Wholly Owned Subsidiaries
CARMEL, Ind., July 29, 2009– Dormir, Inc., an integrated provider of sleep diagnostic services, sleep therapy, and equipment to patients and their physicians, today announced that the company has closed a Series A financing round of $12 million with [...]

Convey Computer Secures $24 Million Series B Financing for Greener, High Performance Computers

Significant Venture Capital Investment Will Increase Global Presence and Drive Product Production; New Members Join Convey Board
RICHARDSON, Texas, July 29, 2009– Convey Computer Corporation, the pioneer of hybrid-core computing – a technology designed to help high-performance computers run faster while significantly reducing the energy they use – announced today it has closed $24.15 million in [...]

Pepperdine University National Study Shows Private Capital Providers Have Very High Expectation for Return on Investment

Venture Capital Lenders Expect 42%, Private Equity Groups Expect 25%, Asset-Based Lenders Expect 11%, Mezzanine Funds Expect 18%, Senior Lenders Expect 6.5% Annual Return on New Investment
Study Also Shows Top Lenders Expect Interest Rates to Climb, U.S. Gross Domestic Product to Be Flat or Decrease in the Next 12 Months and Lending and Investment [...]

Lingotek Closes Internal Financing Round

SALT LAKE CITY, July 28, 2009– Lingotek (www.lingotek.com) today announced it has completed a round of internal financing. The financing included investments from In-Q-Tel, Canopy Ventures and Flywheel Ventures. This new round of funding positions Lingotek to expand its product development, marketing and sales activities and other general corporate activities.
“Lingotek has demonstrated that its [...]

aTyr Pharma Raises an Additional $12 Million

Investors add $12 M to Expand Discovery and Development of a New Class of Protein Therapeutics
SAN DIEGO, July 28, 2009– aTyr Pharma announced today that it has raised an additional $12 million to fund its discovery operations and development of its lead candidate. The company is discovering and developing biotherapeutics to treat a wide variety [...]